Zyprexa News

Zyprexa News

Zyprexa is frequently in the headlines of many media organizations, but it is doubtful Eli Lilly & Co desires the types of publicity their product receives. Numerous individual and class action lawsuits in recent months have cast new light on the dangers Zyprexa poses to uninformed patients. As media outlets focus more and more on the cases of diabetes, stroke, and obesity caused by Zyprexa, those who prescribe and take the drug have a greater knowledge of the risks it poses which could possibly save lives. In addition to being lambasted in print and on the internet, Zyprexa has been the news topic of numerous radio and television talk shows, and continues to fuel nationwide debate on the role negligence and responsibility of pharmaceutical companies worldwide.

Click on the links below to read recent news articles about Zyprexa:

Lilly and Plaintiffs' Attorneys Enter Into an Agreement in Principle to Settle Majority of Zyprexa(R) Product Liability Litigation

Lawsuit Launched Over Antipsychotic Drug

FDA Warns Of Antipsychotic, Antihistamine Drug Mixup

Antipsychotic Drugs Raise Diabetes Risk

Caution Urged on Anti-Psychotic Drugs

Lilly Warns of Zyprexa Risk for Elderly

Discovery Limited In Zyprexa Case

Zyprexa, Risperdal and Clozaril May Increase Risk of Pancreatitis

  • - -
  • By clicking the "Submit" button below, you agree that law firms you are matched with may contact you by telephone even if you are on a federal or state Do Not Call registry. Up to 10 law firms may respond to your request within approximately 2 weeks. In some cases 3 or more firms may respond to your request after 30 days. Use of this site is subject to our Terms of Use.


Website Design & Web Positioning by Wise Law Group

Copyright ©2012- All rights reserved | Terms of Use

[an error occurred while processing this directive]